Asthma Management During Pregnancy

Introduction to Asthma Management

The goal of asthma management during pregnancy is to provide optimal therapy to maintain control of asthma for maternal health and quality of life as well as for normal fetal maturation, as stated by the American Academy of Allergy, Asthma, and Immunology 1
Maintaining asthma control is crucial, as poorly controlled asthma poses greater risks to mother and fetus than medication side effects, according to the European Respiratory Society 2

More safety data exists for budesonide during pregnancy than for other inhaled corticosteroids, according to the American Academy of Allergy, Asthma, and Immunology 1
Monthly evaluations of asthma status and pulmonary function are recommended during pregnancy, as suggested by the American Academy of Allergy, Asthma, and Immunology 1
Spirometry is preferred for initial assessment and follow-up monitoring, as recommended by the American Academy of Allergy, Asthma, and Immunology 1
Consider serial ultrasound examinations starting at 32 weeks for patients with moderate to severe or suboptimally controlled asthma, with a moderate strength of evidence based on expert opinion 1

The diagnosis of asthma in pregnant women should follow standard diagnostic protocols with spirometry as the essential objective measure, considering physiological changes of pregnancy and prioritizing maternal and fetal safety, as recommended by the American College of Allergy, Asthma, and Immunology 3
A medical history should focus on recurrent episodes of respiratory symptoms, pattern and triggers of symptoms, family history of asthma or allergic conditions, and response to previous treatments 3
Common conditions to consider in pregnant women with asthma symptoms include physiologic dyspnea of pregnancy, vocal cord dysfunction, gastroesophageal reflux disease, obstructive sleep apnea, pulmonary embolism, and heart failure, as noted by the American College of Allergy, Asthma, and Immunology 3

The National Asthma Education and Prevention Program recommends budesonide as the preferred inhaled corticosteroid during pregnancy due to its reassuring safety profile, and albuterol is the preferred short-acting beta-2 agonist for use during pregnancy, with extensive experience and no evidence of fetal injury from short-acting inhaled beta-2 agonists 1
For mild intermittent asthma, albuterol (Ventolin) should be used as needed, while for mild persistent asthma, daily low-dose budesonide (Pulmicort) plus albuterol as needed is recommended 1
For moderate persistent asthma, options include low-dose inhaled corticosteroid plus long-acting beta-2 agonist or medium-dose inhaled corticosteroid, with no clear evidence favoring one option over the other during pregnancy 1
For severe persistent asthma, high-dose inhaled corticosteroid (preferably budesonide) and addition of systemic corticosteroids if needed are recommended 1

Albuterol inhaler dosing options include:

Dosing Option	Dosage
Nebulizer	2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed
MDI with spacer	4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed

Salmeterol is preferred over formoterol (longer safety history) as a long-acting beta-2 agonist, as suggested by the American College of Allergy and Clinical Immunology 1

Spirometry is preferable for routine monitoring, but peak flow meter measurements are generally sufficient, and monthly monitoring of asthma symptoms throughout pregnancy is crucial for optimal management 1, 2
Patient education on self-monitoring, proper inhaler technique, and avoiding triggers (especially tobacco smoke) is essential, as suggested by the American College of Allergy and Clinical Immunology 1
A written asthma action plan specific for pregnancy should be provided, with a high strength of evidence based on multiple studies, and follow-up should be arranged within 1-2 weeks, as recommended by the American College of Allergy, Asthma, and Immunology 4, 1
Trigger avoidance, including identification and minimization of exposure to asthma triggers, is essential for managing asthma during pregnancy, as recommended by the European Respiratory Society 2
Vitamin D supplementation may be considered for pregnant women with asthma, as low levels are associated with adverse respiratory outcomes in infants, according to the European Respiratory Society 2

Systemic corticosteroids, such as prednisone, effectively treat moderate to severe asthma exacerbations, with a recommended dosage of 40-60 mg/day for outpatient treatment and 120-180 mg/day in 3-4 divided doses for 48 hours for severe exacerbations, as recommended by the American College of Allergy, Asthma, and Immunology 1
Ipratropium bromide can be added for severe exacerbations, with dosing options including:
Dosing Option Dosage
Nebulizer 0.5 mg every 20 minutes for 3 doses, then as needed
MDI 8 puffs every 20 minutes as needed up to 3 hours
Hospitalization should be considered for failure to respond to initial emergency treatment, PEF or FEV1 <70% of predicted after initial treatment, persistent hypoxemia, history of severe asthma requiring intubation, or presence of high-risk comorbidities, with a moderate strength of evidence based on expert opinion 1

Dosing Option	Dosage
Nebulizer	0.5 mg every 20 minutes for 3 doses, then as needed
MDI	8 puffs every 20 minutes as needed up to 3 hours

Breastfeeding is encouraged and may help prevent allergies in infants, particularly those at higher risk, when continued for at least 4 months, as recommended by the European Respiratory Society 2
Acetaminophen (Tylenol) is considered the safest analgesic and antipyretic during pregnancy and postpartum, and should be used at the lowest effective dose for the shortest time possible, according to the American College of Obstetricians and Gynecologists 5